In NSCLC patients with DVT or metastasis, plasma TFPI-1 levels were significantly higher than that in patients without DVT or metastasis (t: 24.644, P < 0.001; t: 20.021, P < 0.001, resp). This evidence concerns the gene TFPI and non-small cell lung carcinoma.